Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH)
Clinical trial NCT02265952 · COMPLETED
Trial details
- NCT number
- NCT02265952
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-04
- Primary completion
- 2016-11-21
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.